245 related articles for article (PubMed ID: 29564621)
1. Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma.
Sivik JM; Davidson J; Hale CM; Drabick JJ; Talamo G
Support Care Cancer; 2018 Sep; 26(9):3055-3061. PubMed ID: 29564621
[TBL] [Abstract][Full Text] [Related]
2. The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Guare EG; Hale CM; Sivik J; Lehman E; Inoue Y; Rakszawski K; Songdej N; Nickolich M; Zheng H; Naik S; Claxton D; Rybka W; Hohl R; Mineishi S; Minagawa K; Paules CI
Transpl Infect Dis; 2024 Apr; 26(2):e14241. PubMed ID: 38269469
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
Copeland V; McLaughlin M; Trifilio S
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29080369
[TBL] [Abstract][Full Text] [Related]
5. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
[TBL] [Abstract][Full Text] [Related]
6. Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Kim JH; Goulston C; Zangari M; Tricot G; Boyer MW; Hanson KE
Transpl Infect Dis; 2014 Jun; 16(3):421-9. PubMed ID: 24797543
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.
Yeshurun M; Vaxman I; Shargian L; Yahav D; Bishara J; Pasvolsky O; Wolach O; Lahav M; Gurion R; Magen H; Vidal L; Herscovici C; Peck A; Moshe M; Sela-Navon M; Naparstek E; Raanani P; Rozovski U
Clin Microbiol Infect; 2018 Jul; 24(7):749-754. PubMed ID: 29208561
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) - a single-center experience.
Wolska A; Robak T; Szmigielska-Kaplon A; Pluta A; Kopka P; Wierzbowska A
Adv Med Sci; 2012 Jun; 57(1):118-23. PubMed ID: 22366265
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Maakaron JE; Liscynesky C; Boghdadly ZE; Huang Y; Agyeman A; Brammer J; Penza S; Efebera Y; Benson D; Rosko A; William B; Jaglowski SM
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e198-e201. PubMed ID: 32304873
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
Rambaran KA; Seifert CF
J Oncol Pharm Pract; 2019 Jun; 25(4):884-890. PubMed ID: 30041584
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
[TBL] [Abstract][Full Text] [Related]
12. Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Christoforidou AV; Saliba RM; Williams P; Qazilbash M; Roden L; Aleman A; Weber D; Mendoza F; Podoloff D; Wendt R; Breitz H; Alexanian R; Champlin R; Giralt S
Biol Blood Marrow Transplant; 2007 May; 13(5):543-9. PubMed ID: 17448913
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
14. Infectious Complications in Patients With Multiple Myeloma After High-Dose Chemotherapy Followed by Autologous Stem Cell Transplant: Nationwide Study of the Infectious Complications Study Group of the Polish Adult Leukemia Group.
Waszczuk-Gajda A; Drozd-Sokołowska J; Basak GW; Piekarska A; Mensah-Glanowska P; Sadowska-Klasa A; Wierzbowska A; Rzepecki P; Tomaszewska A; Mańko J; Hus M; Adamska M; Romejko-Jarosińska J; Dybko J; Biernat M; Kyrcz-Krzemień S; Sędzimirska M; Winciorek N; Jędrzejczak WW; Styczyński J; Giebel S; Gil L
Transplant Proc; 2020 Sep; 52(7):2178-2185. PubMed ID: 32217016
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Oliver AC; Riva E; Mosquera R; Galeano S; Pierri S; Bello L; Caneiro A; Gai R; Miller A; Muxi P
Ann Hematol; 2020 Apr; 99(4):877-884. PubMed ID: 32062742
[TBL] [Abstract][Full Text] [Related]
16. High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
Musso M; Messina G; Marcacci G; Crescimanno A; Console G; Donnarumma D; Scalone R; Pinto A; Martino M
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1932-8. PubMed ID: 26099830
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation.
Mürner CM; Stenner-Liewen F; Seifert B; Mueller NJ; Schmidt A; Renner C; Schanz U; Knuth A; Manz MG; Scharl M; Gerber B; Samaras P
Leuk Lymphoma; 2019 Mar; 60(3):685-695. PubMed ID: 30126310
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
[TBL] [Abstract][Full Text] [Related]
19. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.
Rodríguez-Lobato LG; Martínez-Roca A; Castaño-Díez S; Palomino-Mosquera A; Gutiérrez-García G; Pedraza A; Suárez-Lledó M; Rovira M; Martínez C; Fernández de Larrea C; Cibeira MT; Rosiñol L; Lozano E; Marín P; Cid J; Lozano M; Moreno-Castaño AB; Palomo M; Díaz-Ricart M; Gallego C; Hernando A; Segura S; Carreras E; Urbano-Ispizua Á; Bladé J; Fernández-Avilés F
PLoS One; 2020; 15(11):e0241778. PubMed ID: 33147257
[TBL] [Abstract][Full Text] [Related]
20. Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.
Therriault BL; Wilson JW; Barreto JN; Estes LL
Mayo Clin Proc; 2010 Aug; 85(8):711-8. PubMed ID: 20675508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
